CA2000420A1 - Peptides representant des epitopes sur le fragment r-ifn-beta, anticorps contre lesdits peptides et applications - Google Patents

Peptides representant des epitopes sur le fragment r-ifn-beta, anticorps contre lesdits peptides et applications

Info

Publication number
CA2000420A1
CA2000420A1 CA2000420A CA2000420A CA2000420A1 CA 2000420 A1 CA2000420 A1 CA 2000420A1 CA 2000420 A CA2000420 A CA 2000420A CA 2000420 A CA2000420 A CA 2000420A CA 2000420 A1 CA2000420 A1 CA 2000420A1
Authority
CA
Canada
Prior art keywords
antibodies
beta
ifn
epitopic sites
peptides representing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2000420A
Other languages
English (en)
Other versions
CA2000420C (fr
Inventor
Paul D. Hoeprich, Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Berlex Laboratories Inc
Original Assignee
Triton Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Triton Biosciences Inc filed Critical Triton Biosciences Inc
Publication of CA2000420A1 publication Critical patent/CA2000420A1/fr
Application granted granted Critical
Publication of CA2000420C publication Critical patent/CA2000420C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/249—Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002000420A 1988-10-14 1989-10-11 Peptides representant des epitopes sur le fragment r-ifn-beta, anticorps contre lesdits peptides et applications Expired - Fee Related CA2000420C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25765188A 1988-10-14 1988-10-14
US257,651 1988-10-14

Publications (2)

Publication Number Publication Date
CA2000420A1 true CA2000420A1 (fr) 1990-04-14
CA2000420C CA2000420C (fr) 2000-12-19

Family

ID=22977172

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002000420A Expired - Fee Related CA2000420C (fr) 1988-10-14 1989-10-11 Peptides representant des epitopes sur le fragment r-ifn-beta, anticorps contre lesdits peptides et applications

Country Status (7)

Country Link
US (1) US5869603A (fr)
EP (1) EP0440686B1 (fr)
JP (1) JP2717319B2 (fr)
AT (1) ATE132502T1 (fr)
CA (1) CA2000420C (fr)
DE (1) DE68925365T2 (fr)
WO (1) WO1990003982A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6514729B1 (en) 1999-05-12 2003-02-04 Xencor, Inc. Recombinant interferon-beta muteins
US7272636B2 (en) * 2001-04-24 2007-09-18 Sun Microsystems, Inc. Peer group name server
JP2005029471A (ja) * 2001-06-26 2005-02-03 Toray Ind Inc ペプチドの立体構造モチーフおよび３次元構造座標ならびにそれらの使用
US20040086874A1 (en) * 2002-10-31 2004-05-06 Parker Russell A. Devices and methods for holding a biopolymeric array
HRP20230605T1 (hr) 2016-04-29 2023-09-29 Pfizer Inc. Protutijela protiv interferona beta i njihova upotreba

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4311639A (en) * 1980-07-25 1982-01-19 E. I. Du Pont De Nemours And Company Immunogenic interferon peptides
GB8412564D0 (en) * 1984-05-17 1984-06-20 Searle & Co Structure and properties

Also Published As

Publication number Publication date
ATE132502T1 (de) 1996-01-15
JP2717319B2 (ja) 1998-02-18
DE68925365D1 (de) 1996-02-15
DE68925365T2 (de) 1996-09-12
JPH07508494A (ja) 1995-09-21
CA2000420C (fr) 2000-12-19
EP0440686B1 (fr) 1996-01-03
EP0440686A1 (fr) 1991-08-14
US5869603A (en) 1999-02-09
WO1990003982A1 (fr) 1990-04-19

Similar Documents

Publication Publication Date Title
FI923246A7 (fi) Sits, speciellt foer fordon.
CA2021912A1 (fr) Peptides d'erythropoietine (epo) et anticorps contre lesdits peptides
DE59000900D1 (de) Rundfunkempfaenger, insbesondere fahrzeugempfaenger.
CA2114015A1 (fr) Anticorps recombinants pour la therapie humaine
IE870074L (en) 4,5,6 - substituted -2- pyrimidinamines
CA2103059A1 (fr) Methode de production d'anticorps humanises
EP0671951A4 (fr) Anticorps humanises reagissant avec l-selectine.
EP0668298A4 (fr) Copolymere maleique, son procede d'obtention et son utilisation.
IT8019296A0 (it) Sedile, specialmente sedile per passeggeri.
IE781670L (en) Substituted propenylamines.
CA2081150A1 (fr) Utilisation de preparations contenant des anticorps pour l'immunosuppression
FR2674481B1 (fr) Toit de vehicule comprenant un couvercle et un pavillon coulissant, notamment independamment du couvercle.
ATE120233T1 (de) Monoklonale antikörper, b-spezifisch für apolipoprotein, die von zwei hybridomen erzeugt werden.
IL98769A0 (en) Synthetic peptides,mixtures thereof and methods utilizing the same for detecting hiv antibodies
CA2000420A1 (fr) Peptides representant des epitopes sur le fragment r-ifn-beta, anticorps contre lesdits peptides et applications
AU519072B2 (en) 1, 1, 1, 2-tetrafluorotha. e
AU5809290A (en) Monoclonal antibodies involved in alzheimer's disease, hybridomas secreting these monoclonal antibodies, antigen recognized by these antibodies, and their application
RO84911A (fr) Procede pour la preparation des 1,1-alcandioles carboxyles
EP0613899A3 (fr) Dérivé de la cocaine, son conjugate de protéine, lignée cellulaire produisant un anticorps monoclonal, procédé de production de la lignée cellulaire et anticorps monoclonal.
CA2080408A1 (fr) Norme artificielle et serums de controle, methodes de preparation et utilisation
AU7504691A (en) Monoclonal antibodies against pp4, processes for the preapration thereof and the use thereof
IE780582L (en) PYRIDO [2,1-b] QUINAZOLINES
IE780570L (en) Mono-5-substituted-thiadiazinones
FI914839L (fi) Effektkrets foer anslutna spaenningsinverterare, vilken har (2*n+l) spaenningsnivaoer.
EP0350218A3 (en) Monoclonal antibodies recognizing gamma atrial natriuretic polypeptide, hybridomas producing such antibodies, and their preparation and use

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed